Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MELA Sciences Inc Closes $6.0 Million Registered Offering


Friday, 1 Nov 2013 08:00am EDT 

MELA Sciences Inc announced the closing of its previously announced registered offering. The Company received gross proceeds of $6.0 million from the sale of 4,228,181 shares of its common stock, fully paid prefunded warrants to purchase up to 4,343,247 shares of its common stock and additional warrants to purchase up to 6,857,142 shares of its common stock. The Series A Warrants are exercisable beginning 6 months following issuance at a price of $0.85 per share and expire five years from the date on which the warrants are initially exercisable. Exercise of the Series A Warrants could result in additional proceeds to the Company of approximately $5.8 million. The Series B Warrants are exercisable immediately for no additional consideration. Craig-Hallum Capital Group acted as exclusive placement agent in connection with this registered offering. Net proceeds to the Company at the closing were approximately $5.5 million. MELA Sciences, Inc. intends to use the net proceeds from this offering to continue the commercial launch of MelaFind in the U.S. and the European Union, for continued research & development activities and for general corporate purposes, including working capital. 

Company Quote

1.33
-0.01 -0.75%
17 Dec 2014